Journals / Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi / 2016 / Cilt: 27 - Sayı: 1

Analysis of Bonsai-Associated Respiratory/Cardiovascular Complications: University Hospital Experience

Bonzai-İlişkili Solunumsal/Kardiyovasküler Komplikasyonların Analizi: Üniversite Hastanesi Deneyimi

Pages
16–20
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Use of products such as "bonsai" may cause death by respiratory depression.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: The aim of the present study was to analyze the gradually increasing number of patients who admit during emergency room admittance to having used a synthetic cannabinoid derivative, "bonsai."Methods: Patients who admitted to having used "bonsai" and with symptoms of respiratory/cardiovascular complications were included.
📊
Key Findings & Data:Data were analyzed using frequencies and chi-square tests.Results: Of the 24 patients with complications that matched the inclusion criteria, the data of 20 patients were examined.
💡
Conclusion & Impact:Use of products such as "bonsai" may cause death by respiratory depression.
🔬Design:Lab & Field Experiment
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background: The aim of the present study was to analyze the gradually increasing number of patients who admit during emergency room admittance to having used a synthetic cannabinoid derivative, "bonsai."Methods: Patients who admitted to having used "bonsai" and with symptoms of respiratory/cardiovascular complications were included. Electrocardiogram findings, vital signs, and blood gas values were recorded in a database and pooled for analysis. Data were analyzed using frequencies and chi-square tests.Results: Of the 24 patients with complications that matched the inclusion criteria, the data of 20 patients were examined. While 3 (15%) patients had Glasgow Coma Scores (GCSs) >13, 12 (60%) had GCSs of 9-13, and 5 (25%) had GCSs 45 mmHg.Conclusion: Synthetic cannabinoid derivatives such as "bonsai" are easy to obtain. It should be remembered that the components change continuously and may cause different side effects. Use of products such as "bonsai" may cause death by respiratory depression.

Özet

Amaç: Bu çalışmada, hastane başvuruları giderek artan sentetik kannabinoid türevi "bonzai" adlı maddeyi kullanım sonrası acil servise başvuran hastaların genel analizini yapmayı amaçladık.Gereç ve Yöntem: Bonzai isimli maddeyi kullanım sonrası solunumsal veya kardiyovasküler komplikasyon gelişen hastaları çalışmaya aldık. Analiz için toplanmış olan elektrokardiogram ve vital bulgular sonuçları, kan gazı sonuçları veri tabanına kaydedildi. Veriler frekans ve ki-kare testi kullanılarak analiz edildi. Bulgular: Çalışmaya dahil edilme kriterlerine sahip 24 hastadan bilgilerine eksiksiz ulaşılan 20 hasta çalışmaya alındı. Hastaların Glaskow Koma Skoru (GKS) 3'ünde (%15) >13, 12'sinde (%60) 9-13 arasında iken 5'inin (%25) 45 mmHg saptandı.Sonuç: "Bonzai" gibi sentetik kannabinoid türevlerine ulaşım çok kolaydır. İçeriği sürekli değişen bu maddelerin değişkenlik gösteren yan etki profilleri dikkate alınmalıdır; Bonzai preperatları kullanımıyla özellikle solunum depresyonuna bağlı ölümler gerçekleşebilir.

🔖

Cite This Article

AKOĞLU, H., ONUR, Ö., EROĞLU, S. E., DENİZBAŞI, A., GÜMÜŞEL, M., KABAROĞLU, K. A., SALÇIN, E. (2022). Analysis of Bonsai-Associated Respiratory/Cardiovascular Complications: University Hospital Experience. Kartal Eğitim ve Araştırma Hastanesi Tıp Dergisi, Cilt: 27 - Sayı: 1, 16–20. https://ajindex.com/articles/568778

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Evren C, Bozkurt M. Sentetik kannabinoidler: Son yılların krizi. Düşünen Adam. The Journal of Psychiatry and Neurological Sciences 2013;26:1-11
  2. Gaoni Y, Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J Am Chem Soc 1964;86:1646-47
  3. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002;54:161-202
  4. UNODC, World Drug Report 2011. United Nation Office on drugs and crime. United Nation Publications 2011;175-93
  5. Erowid Center. Documenting the complex relationship between humans & psychoactives. Available at: http:// www.erowid.org/. Accessed April 7, 2012
  6. Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med 2012;60:435-8
  7. Moosmann B, Kneisel S, Girreser U, Brecht V, Westphal F, Auwärter V. Withdrawal phenomena and dependence syndrome after the consumption of "spicegold". Dtsch Arztebl Int 2009;106:464-67
  8. Castellanos D, Singh S, Thornton G, Avila M, Moreno A. Synthetic cannabinoid use: a case series of adolescents. J Adolesc Health 2011;49:347-9
  9. Every-Palmer S. Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals. Addiction 2010;105:1859-60
  10. Schneir AB, Cullen J, Ly BT. "Spice" girls: synthetic cannabinoid intoxication. J Emerg Med 2011;40:296-9
  11. Vardakou I, Pistos C, Spiliopoulou Ch. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett 2010;197:157-62
  12. Wood DM, Dargan PI. Novel psychoactive substances: how to understand the acute toxicity associated with the use of these substances. Ther Drug Monit 2012;34:363- 7. 13. 2011 National report (2010 data) to the EMCDDA. "TUR- KEY" New Development, Trends and in-depth information on selected issues. Reitox National Focal Point, 2012. http://www.emcdda. europa.eu/attachements. cfm/att_191577_EN_Turkey_2011.pdf. Last accessed February 18, 2013
  13. AAPCC Issues Statement on the Synthetic Drug Abuse Prevention Act. American Association of Poison Control Centre, 2012. http://www.aapcc.org/press/2/. Accessed February 21, 2013
  14. Vandrey R, Dunn KE, Fry JA, Girling ER. A survey study to characterize use of Spice products (synthetic cannabinoids). Drug Alcohol Depend 2012;120:238-4